Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
All >

Deals > Western Europe

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Western Europe or involving organisations from these countries.

Total search results: 6966 | Ordered by Date (descending)
1 2 3 ... 68 69 70  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Evotec–Leucadia: investor conference, 201906 supply service Evotec AG presents at Jefferies 2019 Global Healthcare Conference NYC 2019-06-06
Affimed–Leucadia: investor conference, 201906 supply service Affimed presents at Jefferies 2019 Global Healthcare Conference NY 2019-06-05
Evotec–Deutsche Bank: investor conference, 201906 supply service Evotec presents at dbAccess Berlin Conference 2019-06-05
Kiadis–Leucadia: investor conference, 201906 supply service Kiadis presents at Jefferies 2019 Global Healthcare Conference NYC 2019-06-04
Medigene–Leucadia: investor conference, 201906 supply service Medigene presents at Jefferies Global Healthcare Conference NY 2019-06-04
Spindiag–SEVERAL: investment, 201906 financing round Series A exansion additional €4m incl new investor WBG Pflegeheime 2019-06-04
Yukin Therapeutics–Advent France Biotechnology: investment, 201906 financing round totalling €3.3m incl founding + co-lead investor Advent France Bio 2019-06-04
Yukin Therapeutics–Medicxi: investment, 201906 financing round totalling €3.3m incl new + co-lead investor Medicxi 2019-06-04
Yukin Therapeutics–NewCap: public relations, 201906 service existent by NewCap 2019-06-04
Yukin Therapeutics–SEVERAL: investment, 201906 financing round €3.3m co-led by Advent France Biotechnology + Medicxi 2019-06-04
Adrenomed–BIO (US): partnering conference, 201906 supply service Adrenomed presents at BIO International Convention 2019-06-03
Bruker Corp–PreOmics: sample preparation technology, 201905– collab developm + marketing PreOmics iST sample preparation on timsTOF Pro MS system 2019-05-31
Helmholtz–Bruker Corp: mass spectrometry software 2019-05-31
Helmholtz–Bruker Corp: mass spectrometry software, 201905 supply existent HIPS long-time user of SCiLS Lab + MetaboScape s/w 2019-05-31
Medical Univ South Carolina–Bruker Corp: mass spectrometer, 201905 supply existent timsTOF fleX system early customer Proteomics Center at Med Univ SC 2019-05-31
BlueHaven Therapeutics–MC Services: public relations, 201905 service existent IR by MC Services 2019-05-30
Kiadis–SEVERAL: investment, 201905 private placment €27.6m with 3.68m new shares at €7.5/share 2019-05-30
Bayer–Roche: molecular companion diagnostics, 201905– collab ww €na developm + commercialisation o fNGS-based CDx in oncology 2019-05-29
Domain Therapeutics–BPCE: investment, 201905 investment €3.5m from existing investor Seventure Partners 2019-05-28
Sensorion–Institut Pasteur: gene therapy, 201905– collab framework agreem incl license options for gene therapies for ear diseases 2019-05-27
Biocrates–NONE: investment, 201905– bankruptcy filed for subsidiary Metanomics Health GmbH 2019-05-22
Cubuslab–Labfolder: investment, 201905 acquisition merger of Cubuslab Gmbh + Labfolder GmbH + new name Labforward GmbH 2019-05-22
Evotec–RBC Capital Markets: investor conference, 201905 supply service Evotec presents at RBC Capital Markets Global Healthcare Conference 2019-05-22
Kiadis–Be The Match: cell therapy, 201905– collab logistical + technological solutions for ATIR101 developm in US + CA by Be The Match 2019-05-22
Evotec–Berenberg: investor conference, 201905 supply service Evotec presents at Berenberg European Conference USA in Tarrytown 2019-05-21
Adrenomed–Informa: investor conference, 201905 supply service Adrenomed presents at BioEquity Europe 2019 in Barcelona 2019-05-20
JnJ–Owlstone: breath analyser, 201905– collab developm breath-based test for early detection of pulmonary hypertension with Actelion 2019-05-20
Just Biotherapeutics (US)–Evotec: investment, 201905– acquisition 100% for $60m upfront + $30m upfront 2019-05-20
Storm Therapeutics–Merck (DE): investment, 201905 financing round Series A extension totalling £14m incl existing investor M Ventures 2019-05-20
DNA Script–France (govt): investment, 201905 financing round Series B totalling $38.5m incl new investor Bpifrance Large Venture fund 2019-05-16
DNA Script–Idinvest Partners: investment, 201905 financing round Series B totalling $38.5m incl existing + co-investor Idinvest Partners 2019-05-16
DNA Script–Illumina: investment, 201905 financing round Series B totalling $38.5m incl existing + co-investor Illumina Ventures 2019-05-16
DNA Script–Kurma: investment, 201905 financing round Series B totalling $38.5m incl existing + co-investor Kurma Partners 2019-05-16
DNA Script–Life Sciences Partners: investment, 201905 financing round Series B totalling $38.5m incl new + lead investor LSP 2019-05-16
DNA Script–Merck (DE): investment, 201905 financing round Series B totalling $38.5m incl existing + co-investor M Ventures 2019-05-16
DNA Script–SEVERAL: investment, 201905 financing round Series B $38.5m led by LSP 2019-05-16
DNA Script–Sofinnova: investment, 201905 financing round Series B totalling $38.5m incl existing + co-investor Sofinnova Partners 2019-05-16
Inovio–Qiagen: molecular companion diagnostics, 201905– collab developm of CDx for VGX-3100 DNA-based immunotherapy for cervical dysplasia 2019-05-16
Navan Technologies–High-Tech Gründerfonds: investment, 201905 seed financing round incl Amgen Ventures + HTGF + Hemi Ventures et al 2019-05-15
TreeFrog Therapeutics–Andrew Lloyd Associates: public relations, 201905 service existent by ALA 2019-05-13
TreeFrog Therapeutics–SEVERAL: investment, 201905 financing round Series A €6.5m led by XAnge + incl Galia Geston et al 2019-05-13
Priavoid–PERSON: investment, 201905c Detlev Riesner recently acquired shares of Priavoid GmbH 2019-05-10
MabVax Therapeutics–BioNTech: investment, 201905 acquisition €na of antibody assets + infrastructure + lab equipment in San Diego 2019-05-08
Therachon–Cowen: investment, 201905 existing investor Cowen 2019-05-08
Therachon–France (govt): investment, 201905 existing investors Bpifrance + Inserm Transfert Initiative 2019-05-08
Therachon–Novo Group: investment, 201905 existing investor Novo Holdings 2019-05-08
Therachon–OrbiMed: investment, 201905 existing investor OrbiMed 2019-05-08
Therachon–Pfizer: investment, 201905 existing investor Pfizer Ventures 2019-05-08
Therachon–Pfizer: investment, 201905– acquisition 100% $340m upfront + $470m milestones excl apraglutide development program 2019-05-08
Therachon–Tekla Capital: investment, 201905 existing investor Tekla Capital Management LLC 2019-05-08
Therachon–Versant Ventures: investment, 201905 existing investor Versant Ventures 2019-05-08
Confo Therapeutics–BioGeneration Ventures: investment, 201905 financing round Series A totalling €30m incl new + lead investor BGV 2019-05-07
Confo Therapeutics–Capricorn Venture Partners: investment, 201905 financing round Series A totalling €30m incl existing + co-investor Capricorn HTF 2019-05-07
Confo Therapeutics–Flanders (govt): investment, 201905 financing round Series A totalling €30m incl existing + co-investor PMV 2019-05-07
Confo Therapeutics–Fund+: investment, 201905 financing round Series A totalling €30m incl new + co-investor Fund+ 2019-05-07
Confo Therapeutics–Perceptive Advisors: investment, 201905 financing round Series A totalling €30m incl new + co-investor Perceptive Advisors 2019-05-07
Confo Therapeutics–Qbic: investment, 201905 financing round Series A totalling €30m incl existing + co-investor Qbic 2019-05-07
Confo Therapeutics–SEVERAL: investment, 201905 financing round Series A €30m led by BGV + co-led by Wellington Partners 2019-05-07
Confo Therapeutics–Univ Michigan: investment, 201905 financing round Series A totalling €30m incl existing + co-investor MINTS 2019-05-07
Confo Therapeutics–V-Bio Ventures: investment, 201905 financing round Series A totalling €30m incl existing + co-investor V-Bio Ventures 2019-05-07
Confo Therapeutics–VIB: investment, 201905 financing round Series A totalling €30m incl existing + co-investor VIB 2019-05-07
Confo Therapeutics–Wellington Partners: investment, 201905 financing round Series A totalling €30m incl new + co-lead investor Wellington Partners 2019-05-07
DyNAbind–High-Tech Gründerfonds: investment, 201905 seed financing round incl new investor HTGF 2019-05-07
DyNAbind–Saxony (govt): investment, 201905 seed financing round incl new investor Technologiegründerfonds Sachsen 2019-05-07
DyNAbind–SEVERAL: investment, 201905 seed financing round from HTGF + TGFS + TUDAG 2019-05-07
DyNAbind–TU Dresden: investment, 201905 seed financing round incl existing investor TUDAG TU Dresden AG 2019-05-07
Merck (DE)–DyNAbind: drug discovery technology, 201905 collab existent marketing of DEL discovery kit with Merck KGaA 2019-05-07
Northwestern Univ–DyNAbind: drug discovery technology, 201905 collab existent with Northwestern Univ Chicago 2019-05-07
OMass–DyNAbind: drug discovery technology, 201905 collab existent with OMass Therapeutics 2019-05-07
Promethera–Ci:z Investment: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Ci:z Investment LLP (JP) 2019-05-07
Promethera–Korea Investment Partners: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Korea Investment Partners 2019-05-07
Promethera–Medipal: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Medipal Holdings Corp 2019-05-07
Promethera–Mirae Asset: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor Mirae Asset Capital 2019-05-07
Promethera–Mitsui: investment, 201905 financing round Series D totalling €39.7m incl existing + co-investor Mitsui & Co Global Investment Inc 2019-05-07
Promethera–SEVERAL: investment, 201905 financing round Series D totalling €39.7m incl Belgian private investors as co-investors 2019-05-07
Promethera–SEVERAL: investment, 201905 financing round Series D €39.7m co-led by Itochu Corp + Shinsei Capital Partners 2019-05-07
Promethera–Shinsei Capital: investment, 201905 financing round Series D totalling €39.7m incl new + co-lead investor Shinsei Capital Partners 2019-05-07
Promethera–Six Snow: investment, 201905 financing round Series D totalling €39.7m incl new + co-investor family office Six Snow 2019-05-07
Sosei–DyNAbind: drug discovery technology, 201905 collab existent with Sosei Heptares 2019-05-07
Cutech (IT)–Symrise: investment, 201905 acquisition of Cutech Srl by Symrise 2019-05-06
Chemical Solutions Ltd–SGS: investment, 201905 acquisition of CSL by SGS 2019-05-03
Amal Therapeutics–Boehringer: cancer drugs, 201905– collab clinical research combi study of ATP128 + BI754091 in colorectal cancer 2019-05-02
AstraZeneca–Transgene: cancer immunotherapy, 201905– collab + license option $10m upfront developm armed oncolytic vaccinia viruses using Invir.IO 2019-05-02
miRdetect–Bremen (govt): investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–High-Tech Gründerfonds: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–OTHER: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–SEVERAL: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
Transgene–Huntsworth: public relations, 201905 service existent by Citigate Dewe Rogerson 2019-05-02
Alentis Therapeutics–Bellevue: investment, 201904 financing round Series A totalling CHF12.5m incl co-lead investor BB Pureos Bioventures 2019-04-30
Alentis Therapeutics–BioMedPartners: investment, 201904 financing round Series A totalling CHF12.5m incl co-lead investor BioMedPartners 2019-04-30
Alentis Therapeutics–France (govt): investment, 201904 financing round Series A totalling CHF12.5m incl co-investor Bpifrance 2019-04-30
Alentis Therapeutics–Instinctif Partners: public relations, 201904 service existent media relations by Instinctif 2019-04-30
Alentis Therapeutics–Schroders: investment, 201904 financing round Series A totalling CHF12.5m incl co-investor Schroder Adveq 2019-04-30
Alentis Therapeutics–SEVERAL: investment, 201904 financing round Series A CHF12.5m co-led by BioMedPartners + BB Pureos Bioventures 2019-04-30
Enzyre–EU (govt): grant, 201904 EFRO grant €2m 2019-04-30
Enzyre–Optimum Strategic Communications: public relations, 201904 service existent by Optimum 2019-04-30
Enzyre–SEVERAL: investment, 201904 closing of seed financing round 2019-04-30
SGS–Veeva Systems: clinical research software, 201904– supply global implementation of Veeva Vault CTMS by SGS 2019-04-30
JnJ–Iktos: drug discovery services, 201904– collab using AI technology for small molecule drug discovery projects Janssen 2019-04-29
Zellkraftwerk–Canopy Biosciences: investment, 201904 acquisition of Zellkraftwerk GmbH by Canopy Biosciences 2019-04-29
1 2 3 ... 68 69 70  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top